STOUGHTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL) today announced the pricing of its offering of $210,000,000 aggregate principal amount of 2.875% convertible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results